Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001568249-26-000005

EVP, CHIEF LEGAL OFFICER, SEC sold 3,844 shares at $21.47 ($82,531)

  • EVP, CHIEF LEGAL OFFICER, SEC acquired 7,515 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Rhodes Jennifer J · EVP, CHIEF LEGAL OFFICER, SEC

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-24 Exercise or conversion : show line 1 in the form +7,515 15,124 D
2026-03-25 Sale : show line 2 in the form −3,844 $21.47 $82,531 11,280 D
Open-market sales · 3,844 sh · avg $21.47 · $82,531

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-24 Exercise or conversion : show line 3 in the form Restricted Stock Units −7,515 22,547 D
Loading xslF345X06/form4-03262026_080308.xml…